Literature DB >> 7004767

Continuous cytotoxic T-cell lines.

K A Smith.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7004767     DOI： 10.1007/978-1-4684-3701-0_4

Source DB:  PubMed          Journal:  Contemp Top Immunobiol        ISSN： 0093-4054


× No keyword cloud information.
  4 in total

1.  Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report.

Authors:  J Bubeník; P Perlmann; M Indrová; J Símová; T Jandlová; J Neuwirt
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Tumour inhibitory effects of TCGF/IL-2/-containing preparations.

Authors:  J Bubeník; M Indrová; P Perlmann; K Berzins; O Mach; J Kraml; A Toulcová
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 3.  The clinical potential of interleukin-2.

Authors:  R T Oliver
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

4.  IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.

Authors:  A Moretta; R S Accolla; J C Cerottini
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.